๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Conversion Disorder

EXPLOration of Processes Involved in Dissociative Identity Disorder (DID) NCT07663890n/a4 sites๐Ÿ“ Carvin๐Ÿ“ Chambray-lรจs-Tours๐Ÿ“ Lille Lille University ยท Tests: Questionnaire and Physical Exam, Interview Neurocognitive Assessment Platform 4 Alzheimer NCT07272811n/a1 site๐Ÿ“ Milan IRCCS San Raffaele Conversion Therapy With RC48, Sintilimab, and SOX for HER2 1+/2+ Unresectable Gastric Cancer NCT07194005Phase 21 site๐Ÿ“ Shanghai Fudan University ยท Tests: Disitamab vedotin(RC48), Sintilimab, S-1, Oxaliplatin Concurrently vs Sequentially Combined HAIC With Targeted and Immunotherapy in Potentially Resectable HCC NCT06041477Phase 31 site๐Ÿ“ Guangzhou Sun Yat-sen University ยท Tests: Oxaliplatin,calcium folinic acid, levofolinic acid, 5-FU, Concurrent Lenvatinib, Concurrent PD-1 antibody, Sequential Lโ€ฆ Use of Imatinib to Convert Triple Negative Breast Cancer Into ER-positive Breast Cancer (I-CONIC) NCT05722795NA1 site๐Ÿ“ Gothenburg Vastra Gotaland Region ยท Tests: Imatinib 400 MG Oral Tablet Conversion Therapy Plus Surgery and Radiotherapy for Retroperitoneal Nodal Metastases in Gastric Cancer NCT07007182Phase 21 site๐Ÿ“ Jinan Jinbo Yue ยท Tests: SOX regimen, CAPEOX regimen, PD-1 inhibitor, Para-aortic lymph node radiotherapy (IMRT to station 16), Capecitabine / Sโ€ฆ Neurofeedback and Well-Being Among People With Co-Occurring Obsessive Compulsive Disorder and Post-traumatic Stress Symptoms NCT07217925NA1 site๐Ÿ“ Detroit Wayne State University ยท Tests: Neuroptimal (Zengar, Inc.) Neurofeedback Evaluation of the Efficacy of Dissociation-Focused Cognitive Behavior Therapy NCT06917209NA8 sites๐Ÿ“ Angers๐Ÿ“ Lille๐Ÿ“ Montpellier University Hospital, Tours ยท Tests: CBT-CD psychotherapy First-in-Human Clinical Trial of STUP-001, an In Vivo Direct Cell Conversion Gene Therapy for AIS-A/B Chronic Spinal Cord Injury NCT06922890Phase 1, Phase 21 site๐Ÿ“ Seoul Yonsei University ยท Tests: STUP-001 Radiotherapy + Systemic Therapy as Conversion Therapy for pMMR/MSS T4M0 Colon Cancer๏ผˆNeo-Color๏ผ‰ NCT06949111Phase 21 site๐Ÿ“ Shijiazhuang Hebei Medical University Fourth Hospital ยท Tests: radiotherapy, CAPOX, Capecitabine, Iparomlimab and Tuvonralimab Injection Impact of Theta Burst Repetitive Transcranial Magnetic Stimulation on the Patient's Self-reported Improvement in Their Motor Functional Neurological Disorder NCT07527403n/a1 site๐Ÿ“ Rennes Hospital Center Guillaume Rรฉgnier ยท Tests: theta-burst rTMS (repetitive transcranial magnetic stimulation) Conversion From Unresectable To Resectable Metastatic Colorectal Cancer. NCT03401294Phase 21 site๐Ÿ“ Regina University of Saskatchewan ยท Tests: FOLFOXIRI and Bevacizumab FOLFOX Combined With Durvalumab (MEDI4736), Bevacizumab, and Stereotactic Body Radiotherapy in Sequential Treatment of Potentially Resectable Locally Advanced Hepatocellular Carcinoma NCT07012798Phase 21 site๐Ÿ“ Tianjin Tianjin Medical University Cancer Institute and Hospital ยท Tests: Durvalumab, Bevacizumab, HAIC of FOLFOX Efficacy and Safety Study of Ultra-early Mobile Stroke Unit Neuroprotection Combined With Revascularization for Acute Ischemic Stroke (EXCELLENT) NCT07119021Phase 41 site๐Ÿ“ Beijing Ruijun Ji ยท Tests: Intravenous thrombolysis + edaravone, IV thrombolysis + placebo (control group) Observational Study on "Functional Overlay" in Patients With Movement Disorders NCT05943652n/a1 site๐Ÿ“ Graz Medical University of Graz ยท Tests: Neurological examination, Anamnesis, Neuropsychological testing, Questionnaires, Tremor recording CIRTEN-Simultaneous Pancreas-Kidney Transplant Recipients NCT03769298Phase 2, Phase 31 site๐Ÿ“ Madison University of Wisconsin, Madison ยท Tests: Envarsus XR Neoadjuvant Comprehensive Treatment for Unresectable Esophageal Cancer NCT06430658Phase 21 site๐Ÿ“ Beijing Cancer Institute and Hospital, Chinese Academy of Medical Sโ€ฆ ยท Tests: Tislelizumab (BGB-A317) with chemoradiotherapy Promoting Improved Functioning Among People Experiencing Stressful Situations NCT06482567NA5 sites๐Ÿ“ Belmont๐Ÿ“ Worcester๐Ÿ“ Detroit University of North Carolina, Chapel Hill ยท Tests: iCOVER, Physical Presence with Reassurance Radical Surgery Versus Non-Surgery in Gastric Cancer Patients With Peritoneal Metastasis After Successful Conversion Therapy NCT07789184Phase 331 sites๐Ÿ“ Beijing๐Ÿ“ Beijing๐Ÿ“ Beijing Hua Huang, MD, PhD ยท Tests: Radical Gastrectomy with D2 Lymphadenectomy, Standard Systemic Therapy for Advanced Gastric Cancer Accelerated TMS for Seizure-Type Functional Neurologic Disorders NCT07059325EARLY Phase 11 site๐Ÿ“ Charleston Medical University of South Carolina ยท Tests: Transcranial Magnetic Stimulation Afatinib Combined With Chemotherapy as Conversion Therapy in Unresectable EGFR Sensitive Mutation-positive Stage III NSCLC NCT06709859Phase 21 site๐Ÿ“ Jinan Shandong Public Health Clinical Center ยท Tests: Afatinib plus chemotherapy as conversion treatment Establishment of an Interdisciplinary Functional Neurological Disorder (FND) Treatment Program and Development of a Clinical Care Pathway for FND NCT06362161n/a1 site๐Ÿ“ Birmingham University of Alabama at Birmingham Virtual Reality in Functional Movement Disorder NCT06393439NA1 site๐Ÿ“ Graz Medical University of Graz ยท Tests: Virtual reality motor task Camrelizumab Combined With Rivoceranib and Hepatic Arterial Infusion Chemotherapy (HAIC) as Conversion Therapy for Potentially Resectable Hepatocellular Carcinoma(HCC) NCT06796803Phase 2, Phase 32 sites๐Ÿ“ Harbin๐Ÿ“ Shanghai Shanghai Zhongshan Hospital ยท Tests: camrelizumab combined with rivoceranib and HAIC, camerlizumab + rivoceranib Development of a Home Test for Measuring Blood P-tau217 in Alzheimer's Disease Using the Tasso Lancet Device NCT07701161n/a5 sites๐Ÿ“ Chicago๐Ÿ“ Dearborn๐Ÿ“ Flint Neurogen Biomarking LLC HAIC, Lenvatinib, and Cadonilimab as Conversion Therapy for Initially Unresectable Hepatocellular Carcinoma NCT06187961Phase 21 site๐Ÿ“ Wuhan Tongji Hospital ยท Tests: Hepatic arterial infusion chemotherapy (HAIC-FOLFOX), Lenvatinib, Cadonilimab XELOX Combined With Fruquintinib and Sintilimab Regimen Conversion Therapy for Gastric Cancer/Gastroesophageal Junction Adenocarcinoma Only With Liver and/or Retroperitoneal Lymph Node Metastasis, a Prospective Single-arm, Multicenter Study NCT06091423Phase 21 site๐Ÿ“ Nanjin Xiaofeng Chen ยท Tests: XELOX combined with Fruquintinib and Sintilimab Surgery for Locally Unresectable Pancreatic Cancer NCT07241663n/a1 site๐Ÿ“ Padova Azienda Ospedaliera di Padova ยท Tests: Questionnaire Study of Tislelizumab Combined With Chemoradiotherapy and Surgery for Unresectable Esophageal Squamous Cell Carcinoma NCT07039162Phase 28 sites๐Ÿ“ Kaohsiung City๐Ÿ“ Kaohsiung City๐Ÿ“ Taichung Ming-Yu Lien ยท Tests: Tislelizumab, Paclitaxel, Cisplatin, Radiation Therapy The Role of 18F-FDG&68Ga-FAPI PET/CT in the Assessment of Conversion Therapy Efficacy in Gastric Cancer with Peritoneal Metastasis. NCT06597526n/a1 site๐Ÿ“ Shanghai Ruijin Hospital
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy